Find therapies in clinical trials near you – page 24

Study of telitacicept compared to placebo in adults with moderate to severe systemic lupus erythematosus

Study of telitacicept compared to placebo in adults with moderate to severe systemic lupus erythematosus

Study of IMG-007 injection to treat moderate to severe atopic dermatitis in adults

Study of IMG-007 injection to treat moderate to severe atopic dermatitis in adults

Study of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

Study of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

Study on the Effectiveness and Safety of JNJ-77242113 and Deucravacitinib for Adults with Moderate to Severe Plaque Psoriasis

Study on the Effectiveness and Safety of JNJ-77242113 and Deucravacitinib for Adults with Moderate to Severe Plaque Psoriasis

Evaluating mezagitamab in adults with late antibody-mediated rejection after kidney transplant

Evaluating mezagitamab in adults with late antibody-mediated rejection after kidney transplant

Study of Benfooxythiamine Monosodium Added to Lutetium‑177 Vipivotide Tetraxetan in Adults with Metastatic Castration‑Resistant Prostate Cancer and Stable Disease

Long-Term Safety Study of JNJ-77242113 in Children with Immune System Disorders

Phase 3 Study of Enfortumab Vedotin plus Pembrolizumab in Adults with Muscle‑Invasive Bladder Cancer Ineligible for Cystectomy

Phase 3 Study of Enfortumab Vedotin plus Pembrolizumab in Adults with Muscle‑Invasive Bladder Cancer Ineligible for Cystectomy

Safety and efficacy of efimosfermin alfa versus placebo in adults with compensated cirrhosis (stage F4) due to MASH

Safety and efficacy of efimosfermin alfa versus placebo in adults with compensated cirrhosis (stage F4) due to MASH

Safety and Efficacy of Efimosfermin Alfa vs Placebo in Adults with Alcohol-Related Liver Disease

Phase 3 Study of Pridopidine Hydrochloride for Safety and Efficacy in Adults with Huntington’s Disease

Phase 3 Study of Pridopidine Hydrochloride for Safety and Efficacy in Adults with Huntington’s Disease

Study of efimosfermin alfa versus placebo in adults with compensated cirrhosis from metabolic dysfunction-associated steatohepatitis (MASH)

Study of efimosfermin alfa versus placebo in adults with compensated cirrhosis from metabolic dysfunction-associated steatohepatitis (MASH)